Indication
Hematopoietic Cell Transplantation
4 clinical trials
4 products
Clinical trial
A Phase I Open-label Dose-escalation Study to Evaluate the Safety of Intramuscular Injections of PLX-R18 in Subjects With Incomplete Hematopoietic Recovery Following Hematopoietic Cell TransplantationStatus: Completed, Estimated PCD: 2021-09-30
Product
PLX-R18Clinical trial
Phase I, Single-arm, Dose-escalation Trial of Tributyrin to Promote Gut Health Among Children Undergoing Hematopoietic Cell TransplantationStatus: Not yet recruiting, Estimated PCD: 2025-11-01
Product
TributyrinClinical trial
High vs. Standard Dose Flu Vaccine in Adult Stem Cell Transplant RecipientsStatus: Active (not recruiting), Estimated PCD: 2022-02-15
Clinical trial
Evaluation of Intravenous Laronidase Pharmacokinetics Before and After Hematopoietic Cell Transplantation in Patients With Mucopolysaccharidosis Type IH.Status: Recruiting, Estimated PCD: 2024-10-01
Product
Laronidase